<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1787725</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2026.1787725</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Implantation of autogenic and decellularized xenogenic grafts for tissue repair in experiment</article-title>
<alt-title alt-title-type="left-running-head">Pechersky et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2026.1787725">10.3389/fcell.2026.1787725</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Pechersky</surname>
<given-names>Alexander V.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1411825"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal Analysis</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pechersky</surname>
<given-names>Viktor I.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing - original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barsuk</surname>
<given-names>Ilya A.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vilyaninov</surname>
<given-names>Vladimir N.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alexandrov</surname>
<given-names>Viktor N.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Semiglazov</surname>
<given-names>Vladimir F.</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2260095"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x26; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/">Writing - review and editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role>
</contrib>
</contrib-group>
<aff id="aff1">
<label>1</label>
<institution>Medical Center</institution>, <city>St. Petersburg</city>, <country country="RU">Russia</country>
</aff>
<aff id="aff2">
<label>2</label>
<institution>Retired</institution>, <city>St. Petersburg</city>, <country country="RU">Russia</country>
</aff>
<aff id="aff3">
<label>3</label>
<institution>Scientific Research Center, Military Medical Academy named after S.M. Kirov</institution>, <city>St. Petersburg</city>, <country country="RU">Russia</country>
</aff>
<aff id="aff4">
<label>4</label>
<institution>Blood and Tissue Center, Military Medical Academy named after S.M. Kirov</institution>, <city>St. Petersburg</city>, <country country="RU">Russia</country>
</aff>
<aff id="aff5">
<label>5</label>
<institution>Scientific Department of Breast Tumors, National Medical Research Center of Oncology named after N.N. Petrov</institution>, <city>St. Petersburg</city>, <country country="RU">Russia</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Alexander V. Pechersky, <email xlink:href="mailto:a_pechersky@mail.ru">a_pechersky@mail.ru</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-27">
<day>27</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>14</volume>
<elocation-id>1787725</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>15</day>
<month>02</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>16</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Pechersky, Pechersky, Barsuk, Vilyaninov, Alexandrov and Semiglazov.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Pechersky, Pechersky, Barsuk, Vilyaninov, Alexandrov and Semiglazov</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-27">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>With extensive tissue damage, the body is unable to restore their integrity on its own. Implantation of autogenic and decellularized xenogenic grafts opens up new possibilities for regeneration of damaged corresponding tissues.</p>
</sec>
<sec>
<title>Methods</title>
<p>The pilot experimental study was conducted on a model of healing of grade III B skin burn wounds in Wistar rats. After removal of the necrotized tissues, autogenous and decellularized xenogenic grafts were implanted into the blood-supplying tissues of the burn wounds.</p>
</sec>
<sec>
<title>Results</title>
<p>The pilot experimental study showed that implantation of autogenic and decellularized xenogenic grafts in the experimental zone led to the formation of multiple regeneration sites, almost ten times higher than the marginal epithelialization of the control zone. The proportion of epithelialization of the experimental zone initiated by the installed grafts was more than 90%, and the proportion of marginal epithelialization of the control zone was less than 10%. The completion of epithelialization of skin burn wounds with a predominance of epithelialization of the experimental zone led to the healing of burn wounds. The tightening of the wound edges by scar tissue was minimal.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>Implantation of autogenic or decellularized xenogenic grafts can potentially be used to repair any tissues after their damage or disease. The results obtained are preliminary, requiring verification on a wider sample of experimental animals. The use of this methodology to repair tissues with a more complex structure than the skin, for increase the functioning of the parenchyma of various organs requires further study.</p>
</sec>
</abstract>
<kwd-group>
<kwd>autogenic and decellularized xenogenic grafts</kwd>
<kwd>innate and acquired immunity</kwd>
<kwd>pluripotent stem cells</kwd>
<kwd>regeneration</kwd>
<kwd>tissue damage</kwd>
<kwd>tissue-specific antigens</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="10"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="12"/>
<page-count count="7"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Stem Cell Research</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<label>1</label>
<title>Introduction</title>
<p>With extensive tissue damage, the body is not able to restore their integrity on its own. To repair extensive tissue damage, decellularized connective tissue (stromal) matrices made from tissues similar to the damaged ones must be transplanted to ensure specific differentiation of migrated pluripotent stem cells (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>). The use of mesenchymal stem cells (<xref ref-type="bibr" rid="B2">Carlos Rodriguez-Merchan, 2022</xref>) and gels made from extracellular matrix (<xref ref-type="bibr" rid="B3">Deng et al., 2025</xref>) is effective for small defects, but cannot ensure the restoration of extensive tissue damage. Mesenchymal stem cells (<xref ref-type="bibr" rid="B4">Dominici et al., 2006</xref>) &#x2013; the precursors of fibroblasts and their derivatives: adipocytes, chondrocytes, and osteocytes (<xref ref-type="bibr" rid="B7">Pechersky, 2016</xref>), are unable to form a specific three-dimensional connective tissue matrix of damaged tissue after transplantation without the influence of the cellular environment that died at the site of injury. Similarly, gels prepared from the extracellular matrix of tissues other than damaged ones contain a set of non-specific cellular growth factors that are unable to provide specific differentiation of migrated pluripotent stem cells into cells of damaged tissues. Currently, there is no generally recognized consensus on the decellularization procedure, which allows preserving the molecular composition of the allogeneic or xenogenic extracellular matrix, and the method of its recellularization (<xref ref-type="bibr" rid="B5">Gentile et al., 2020</xref>). The study of new methods of tissue regeneration in their injuries and diseases, including those leading to a decrease in the functioning parenchyma of organs formed from them, is an actual task facing fundamental and applied medicine.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<label>2</label>
<title>Materials and methods</title>
<p>The aim of the pilot experimental study was to proof of concept of the formation of multiple regeneration sites during implantation of autogenic and decellularized xenogenic grafts into blood-supplied tissues in cases of extensive damage. A grade III B skin burn injury in experimental animals was used as a model of extensive tissue damage. The study was conducted on two Wistar rats (males aged 4 months), each of which received a grade III B skin burn under general anesthesia in two areas to the left and right of the withers. For the thermal burn, a metal cylinder with a diameter of 5&#xa0;cm was used, heated to a temperature of 100&#xb0;&#xa0;C. The exposure was 30&#xa0;s. On day 3, necrotic tissues were removed and grafts were inserted with micro tweezer into cavities formed by a micro scalpel in the underlying tissues, which retained blood supply and viability. Grafts of 2 &#xd7; 2&#xa0;mm made of decellularized and lyophilized xenogenic (pig) skin (Xenoderm biological coating approved for clinical use) were installed in the burn area on the right side. The quality of decellurization of the Xenoderm biological coating is confirmed by the manufacturer&#x2019;s certificate, which excludes the participation of donor (pig) cells in the epithelization of the matrix. The biological coating of Xenoderm, as a stromal matrix of xenogenic skin, was only able to direct the differentiation of migrated own pluripotent stem cells of the experimental animal. Grafts with a diameter of 1&#xa0;mm were placed in the burn area on the left side, which included all layers of the auto skin of the laboratory animal, harvested immediately before implantation from a nearby donor skin area using the graft extraction technique for hair follicle transplantation.</p>
<p>The very fact of epithelialization initiated by established autogenic and decellularized xenogenic grafts was evaluated, as well as the ratio of the epithelialization area from the graft sites (which formed the experimental zone) and marginal epithelialization (which formed the control zone). The comparison of the epithelialization of the experimental and control zones of one wound of one animal ensured the objectivity of the evaluation of the experimental results, regardless of the features of the wound process in different animals.</p>
</sec>
<sec sec-type="results" id="s3">
<label>3</label>
<title>Results</title>
<p>After implantation on days 9&#x2013;18 (days 12&#x2013;21 after thermal injury), autogenous and decellularized xenogenic skin grafts became multiple centers of epithelialization in the experimental zone, which significantly prevailed over the marginal epithelialization of the control zone. The proportion of epithelialization initiated by established grafts was more than 90%, and the proportion of marginal epithelialization was less than 10%. Epithelialization of skin burn wounds with an almost tenfold predominance of epithelization in the experimental zone resulted in wound healing in both areas with autogenic grafts and decellularized xenogenic grafts. The tightening of the wound edges by scar tissue was minimal. The intensity of epithelialization in the experimental zone of both experimental animals was higher on the left, on the implantation side of autogenic skin grafts (<xref ref-type="fig" rid="F1">Figures 1</xref>&#x2013;<xref ref-type="fig" rid="F10">10</xref>). By day 26 (29 days after thermal injury), hair growth began at the site of the completed epithelialization of burn wounds. Histological examination confirmed a grade III B burn - necrosis of all skin layers and additional skin elements (hair follicles and sebaceous glands).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Animal No. 1 (burn area and general appearance &#x2b; donor site), 1st day after graft implantation (4th day after burn injury). The burn area on the left side with implanted auto filament grafts obtained from a nearby donor skin area.</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g001.tif">
<alt-text content-type="machine-generated">A close-up photograph of an oval burn wound of the skin after removal of necrotic tissues and installation of autogenic skin crafts. The second panel shows the same wound and a second skin burn wound on the opposite side after necrectomy, as well as a donor area with traces of preparation of autogenic skin grafts.</alt-text>
</graphic>
</fig>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Animal No. 1, 9th day after graft implantation (12th day after burn injury). The burn area on the left side with implanted auto filament grafts obtained from a nearby donor skin area.</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g002.tif">
<alt-text content-type="machine-generated">Close-up of an oval burn wound with the beginning of epithelialization from the sites of established autogenous grafts.</alt-text>
</graphic>
</fig>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Animal No. 1, 18th day after graft implantation (21st day after burn injury). The burn area on the left side with implanted auto filament grafts obtained from a nearby donor skin area.</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g003.tif">
<alt-text content-type="machine-generated">Close-up photograph of a skin burn wound, most of which is epithelized (mainly from the experimental area of autogenic grafts and, to a lesser extent, from the control area of marginal epithelialization).</alt-text>
</graphic>
</fig>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Animal No. 1, 26th day after graft implantation (29th day after burn injury). The burn area on the left side with implanted auto filament grafts obtained from a nearby donor skin area.</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g004.tif">
<alt-text content-type="machine-generated">Image of the final stage of healing of a burn wound with the beginning of hair growth from the epithelium formed from established autogenous grafts.</alt-text>
</graphic>
</fig>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Animal No. 2, 12th day after graft implantation (15th day after burn injury). The burn area on the left side with implanted auto filament grafts obtained from a nearby donor skin area.</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g005.tif">
<alt-text content-type="machine-generated">A close-up image of the burn wound of the skin of the 2nd animal, showing the beginning of its epithelialization (mainly due to established autogenous skin grafts and, to a much lesser extent, marginal epithelialization).</alt-text>
</graphic>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Animal No. 1, 1st day after graft implantation (4th day after burn injury). The burn area on the right side with implanted grafts of decellularized and lyophilized xenogenic (pig) skin (Xenoderm).</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g006.tif">
<alt-text content-type="machine-generated">Close-up of a burn wound after removal of necrotic tissues and installation of xenogenic grafts.</alt-text>
</graphic>
</fig>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Animal No. 1, 9th day after graft implantation (12th day after burn injury). The burn area on the right side with implanted grafts of decellularized and lyophilized xenogenic (pig) skin (Xenoderm).</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g007.tif">
<alt-text content-type="machine-generated">Close-up of an oval-shaped skin burn wound with the onset of epithelialization from the sites of established xenogenic grafts (predominant) and marginal epithelialization (to a lesser extent).</alt-text>
</graphic>
</fig>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Animal No. 1, 18th day after graft implantation (21st day after burn injury). The burn area on the right side with implanted grafts of decellularized and lyophilized xenogenic (pig) skin (Xenoderm).</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g008.tif">
<alt-text content-type="machine-generated">Close-up of epithelialization of a burn wound caused by established xenogenic grafts and marginal epithelialization.</alt-text>
</graphic>
</fig>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Animal No. 1, 26th day after graft implantation (29th day after burn injury). The burn area on the right side with implanted grafts of decellularized and lyophilized xenogenic (pig) skin (Xenoderm).</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g009.tif">
<alt-text content-type="machine-generated">Close-up photograph of the final stage of healing of a burn skin wound at the site of xenogenic grafts installed with the beginning of hair growth in the epithelialization area.</alt-text>
</graphic>
</fig>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Animal No. 2, 12th day after graft implantation (15th day after burn injury). The burn area on the right side with implanted grafts of decellularized and lyophilized xenogenic (pig) skin (Xenoderm).</p>
</caption>
<graphic xlink:href="fcell-14-1787725-g010.tif">
<alt-text content-type="machine-generated">A close-up of the burn wound of the skin of the 2nd animal, showing its epithelialization from areas of established xenogenic grafts (predominant) and marginal epithelialization (to a lesser extent).</alt-text>
</graphic>
</fig>
</sec>
<sec sec-type="discussion" id="s4">
<label>4</label>
<title>Discussion</title>
<p>An experimental study using the example of epithelialization of animal skin after a grade III B burn injury demonstrated the possibility of restoring damaged tissues through low-traumatic and technically simple implantation of autogenic or decellularized xenogenic grafts forming multiple regeneration sites (<xref ref-type="fig" rid="F1">Figures 1</xref>&#x2013;<xref ref-type="fig" rid="F10">10</xref>). Since the restoration of damaged tissues depends on the ratio of regeneration and fibrosis processes, the predominance of epithelialization (90% of which was initiated by grafts installed in experimental zone) led to minimal tightening of the wound edges by scar tissue and wound healing. The onset of hair growth at the site of burn wounds by day 26 (29 days after thermal injury) was evidence of the restoration of secondary skin elements, hair follicles, during epithelialization (which occurred mainly from graft sites). When scar tissue replaces all layers of necrotic skin with a grade III B skin burn, skin repair, including hair follicles and hair growth, does not occur.</p>
<p>The similarity of the results of epithelialization in both experimental animals with an almost tenfold predominance of epithelialization in experimental zone with established grafts indicates a minimal probability of accidental data acquisition. The histological examination confirmed a grade III B burn - necrosis of all skin layers, which excluded the possibility of subsequent regeneration from cells of additional skin elements (hair follicles and sebaceous glands).</p>
<p>Unlike the transplantation of the donor stromal base of the entire parenchymal organ, which requires connecting its vessels to the recipient&#x2019;s bloodstream to ensure the supply of a sufficient number of pluripotent stem cells (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>), when using autogenic or decellularized xenogenic grafts, their implantation into the recipient&#x2019;s blood-supplied tissues is sufficient.</p>
<p>The preferred explanation for the mechanism of directed migration of pluripotent stem cells to implanted autogenic and decellularized xenogenic grafts is the involvement of the immune system in it, described in the previously proposed immune concept of regeneration (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>). The direction of differentiation of migrated pluripotent stem cells is determined by cellular growth factors of connective tissue located on glycoproteins of intercellular matrix and basement membranes. The sequence and composition of cellular growth factors of glycoproteins of the intercellular matrix and basement membranes form a unique differentiation code of migrated pluripotent stem cells into cells of the corresponding tissues formed during the implementation of the development program (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>; <xref ref-type="bibr" rid="B1">Alberts et al., 1994</xref>). After removal by proteolytic enzymes of parenchymal cells of donor tissues or organs carrying peptide copies of tissue-specific antigens associated with MHC (major histocompatibility complex) class I dimers (HLA in leukocytes) and transplantation of the remaining stromal base, the recipient&#x2019;s tissue structure is restored due to migration of his own pluripotent stem cells and their differentiation into cells of this tissue or organ (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>).</p>
<p>The stromal base of allogeneic and xenogenic tissues and organs, consisting of an intercellular matrix and basement membranes, has low immunogenicity (<xref ref-type="bibr" rid="B1">Alberts et al., 1994</xref>), which is insufficient to initiate differentiation of T-helper (Th) into T-helper 1 (Th 1), forming tissue-specific receptors of cytotoxic T-cells, or into T-helper 2 (Th2), regulating the formation of antibody-producing B-cells. The low immunogenicity of the exposed collagen of the intercellular matrix and basement membranes does not interfere with platelet aggregation producing vasoactive amines and chemoattractants (<xref ref-type="bibr" rid="B12">Roitt et al., 2000</xref>). The latter attract antigen-presenting cells (macrophages, dendritic cells, and others) that initiate the differentiation of T-helper (Th) into T-helper 1 (Th 1), which form tissue-specific receptors in stem cells (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>). Subsequent directed migration of the recipient&#x2019;s own committed pluripotent stem cells with formed tissue-specific receptors provides regeneration - restoration of the donor stromal base into a full-fledged tissue or organ of the recipient (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>; <xref ref-type="bibr" rid="B7">Pechersky, 2016</xref>; <xref ref-type="bibr" rid="B10">Pechersky et al., 2016b</xref>). The leading regenerative function (rather than the protective function) of acquired immunity (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>) is evidenced by the binding of MHC class II molecules of antigen-presenting cells and T-helper (Th) to 99% of the peptide copies of autoantigens and only to 1% of the peptide copies of foreign antigens (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>). Presentation to T-helper of 99% of the peptide copies of autoantigens of dead old and damaged cells are completed by the formation of the same proportion of complementary receptors to autoantigens in pluripotent stem cells (<xref ref-type="bibr" rid="B8">Pechersky et al., 2008</xref>; <xref ref-type="bibr" rid="B9">Pechersky et al., 2016a</xref>; <xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>). Directed migration of pluripotent stem cells is impossible without the formation of tissue-specific receptors. Naturally, local administration of pluripotent stem cells does not lead to their differentiation into tissues cells of the injection site; after administration, pluripotent stem cells, lacking tissue-specific receptors, migrate from the injection site.</p>
<p>The higher intensity of epithelialization of the burn wound, obtained by using autogenic grafts (<xref ref-type="fig" rid="F1">Figures 1</xref>&#x2013;<xref ref-type="fig" rid="F5">5</xref>), indicates the need to improve the production technology of xenogenic decellularized stromal matrices. During their production, it is necessary to preserve their cellular growth factors the unique code of the composition and sequence of which directs the differentiation of migrated pluripotent stem cells into cells of certain tissues from which these matrices are prepared.</p>
<p>Despite the low immunogenicity of xenogenic connective tissue matrices, tissues and organs for their manufacture should be taken from animal donors with a blood type similar to human blood type 0 (I) (having an antigen similar to human factor H of blood type 0 (I)), as universal donors without antigens, interacting with aglutinins &#x3b1; and &#x3b2;. Because blood group antigens are present not only on red blood cells, but also in various tissues (<xref ref-type="bibr" rid="B6">Kosyakov, 1974</xref>), this methodology will minimize the risk of developing innate immunity reactions and secondary developing acquired immunity reactions (<xref ref-type="bibr" rid="B11">Pechersky et al., 2019</xref>).</p>
</sec>
<sec sec-type="conclusion" id="s5">
<label>5</label>
<title>Conclusion</title>
<p>Implantation of autogenic and decellularized xenogenic grafts forming multiple regeneration sites opens up new potential opportunities for tissue repair after their damage or disease. In some cases, this technology may become an alternative for more complex and traumatic transplantation of tissues and organs. The results of the pilot study are preliminary, requiring verification on a wider sample of experimental animals. The use of this methodology to repair tissues with a more complex structure than skin to increase the functioning parenchyma of various organs requires further study.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s6">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s7">
<title>Ethics statement</title>
<p>The animal study was approved by Military Medical Academy named after S.M. Kirov, St. Petersburg, Russia. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s8">
<title>Author contributions</title>
<p>AP: Writing &#x2013; review and editing, Conceptualization, Project administration, Data curation, Formal Analysis, Writing &#x2013; original draft, Methodology. VP: Conceptualization, Writing &#x2013; original draft. IB: Methodology, Project administration, Writing &#x2013; review and editing, Data curation. VV: Project administration, Writing &#x2013; review and editing, Methodology. VA: Project administration, Writing &#x2013; review and editing. VS: Writing &#x2013; review and editing, Supervision.</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s11">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="s12">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Alberts</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bray</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lewis</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Raff</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>J. D.</given-names>
</name>
</person-group> (<year>1994</year>). <source>Molecular biology of the cell</source>, <volume>2</volume>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Mir</publisher-name>, <fpage>176</fpage>&#x2013;<lpage>529</lpage>.</mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carlos Rodriguez-Merchan</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Autologous and allogenic utilization of stromal vascular fraction and decellularized extracellular matrices in orthopedic surgery: a scoping review</article-title>. <source>Arch. Bone Jt. Surg.</source> <volume>10</volume>, <fpage>827</fpage>&#x2013;<lpage>832</lpage>. <pub-id pub-id-type="doi">10.22038/ABJS.2022.59635.2943</pub-id>
<pub-id pub-id-type="pmid">36452418</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ming</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Decellularized tissue matrices hydrogels functionalized with extracellular vesicles promote macrophage reprogramming and neural stem cell differentiation for spinal cord injury repair</article-title>.</mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dominici</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Le Blanc</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mueller</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Slaper-Cortenbach</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Marini</surname>
<given-names>Fc</given-names>
</name>
<name>
<surname>Krause</surname>
<given-names>Ds</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement</article-title>. <source>Cytotherapy</source> <volume>8</volume> (<issue>4</issue>), <fpage>315</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1080/14653240600855905</pub-id>
<pub-id pub-id-type="pmid">16923606</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gentile</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sterodimas</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pizzicannella</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dionisi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>De Fazio</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Calabrese Simone Garcovich</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Systematic review: allogenic use of stromal vascular fraction (SVF) and decellularized extracellular matrices (ECM) as advanced therapy medicinal products (ATMP) in tissue regeneration</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume> (<issue>14</issue>), <fpage>4982</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21144982</pub-id>
<pub-id pub-id-type="pmid">32679697</pub-id>
</mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Kosyakov</surname>
<given-names>P. N.</given-names>
</name>
</person-group> (<year>1974</year>). <source>Human isoantigens and isoantibodies in norm and pathology</source>. <publisher-loc>Moscow: Medicine</publisher-loc>, <fpage>3</fpage>&#x2013;<lpage>360</lpage>.</mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechersky</surname>
<given-names>A. V.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Revisiting terminology and characteristics of stem cells</article-title>. <source>J. Stem Cells</source> <volume>11</volume> (<issue>2</issue>), <fpage>63</fpage>&#x2013;<lpage>67</lpage>.<pub-id pub-id-type="pmid">28296865</pub-id>
</mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechersky</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Pechersky</surname>
<given-names>V. I.</given-names>
</name>
<name>
<surname>Aseev</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Droblenkov</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Semiglazov</surname>
<given-names>V. F.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Several aspects of the regeneration process carried out by means of pluripotent stem cells</article-title>. <source>Tsitologiya</source> <volume>50</volume> (<issue>6</issue>), <fpage>511</fpage>&#x2013;<lpage>520</lpage>.</mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechersky</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Pechersky</surname>
<given-names>V. I.</given-names>
</name>
<name>
<surname>Aseev</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Droblenkov</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Semiglazov</surname>
<given-names>V. F.</given-names>
</name>
</person-group> (<year>2016a</year>). <article-title>Immune system and regeneration</article-title>. <source>J. Stem Cells</source> <volume>11</volume> (<issue>2</issue>), <fpage>69</fpage>&#x2013;<lpage>87</lpage>.<pub-id pub-id-type="pmid">28296866</pub-id>
</mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechersky</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Pechersky</surname>
<given-names>V. I.</given-names>
</name>
<name>
<surname>Shpilenya</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Gaziev</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>Semiglazov</surname>
<given-names>V. F.</given-names>
</name>
</person-group> (<year>2016b</year>). <article-title>Regeneration and cicatrization</article-title>. <source>J. Stem Cells</source> <volume>11</volume> (<issue>2</issue>), <fpage>89</fpage>&#x2013;<lpage>97</lpage>.<pub-id pub-id-type="pmid">28296867</pub-id>
</mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechersky</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Pechersky</surname>
<given-names>V. I.</given-names>
</name>
<name>
<surname>Vilyaninov</surname>
<given-names>V. N.</given-names>
</name>
<name>
<surname>Pecherskaya</surname>
<given-names>O. V.</given-names>
</name>
<name>
<surname>Semiglazov</surname>
<given-names>V. F.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Regeneration&#x2019;s role in the development of desensitization and immunological tolerance</article-title>. <source>J. Stem Cells</source> <volume>14</volume> (<issue>2</issue>), <fpage>75</fpage>&#x2013;<lpage>102</lpage>.</mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Roitt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Brostoff</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Male</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2000</year>). <source>Immunology</source>. <publisher-loc>Moscow</publisher-loc>: <publisher-name>Mir</publisher-name>, <fpage>1</fpage>&#x2013;<lpage>564</lpage>.</mixed-citation>
</ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/990785/overview">Prasad S. Koka</ext-link>, Biomedical Research Institute of Southern California, United States</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3352936/overview">Vladimir Shidin</ext-link>, Tyumen State Medical University, Russia</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3371002/overview">Anna Rastorgueva</ext-link>, Fox Chase Cancer Center, United States</p>
</fn>
</fn-group>
<fn-group>
<fn fn-type="abbr" id="abbrev1">
<label>Abbreviations:</label>
<p>MHC, major histocompatibility complex; HLA, Human Leukocyte Antigens; Th, T-helper.</p>
</fn>
</fn-group>
</back>
</article>